ArriVent BioPharma, Inc.

AVBP • NASDAQ • Stock Fundamentals

ArriVent BioPharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Zhengbin Yao, with a market cap of $1.3B.

Market Cap$1.3B

Employees40.0

CEOZhengbin Yao

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc. (AVBP) has a market capitalization of $1.3B and trades on NASDAQ.

ArriVent BioPharma, Inc. has approximately 40 employees.